Ms. Mayson joined Biologics Consulting in April 2021 and has over two years of biotechnology and pharmaceutical experience. Amber possesses expertise in supporting cross-functional project teams by assisting project leaders within the Vaccines Business Unit with programs in stages ranging from identification of a clinical target through licensure and commercialization.
Amber previously worked for Emergent BioSolutions where she led complex projects with clients such as Spine Biopharma, Novavax, Vaxart, Aicuris and other nationwide clientele. She has also played a valid role leading projects involving COVID-19 pandemic by leading the development and manufacturing of plasma-derived therapeutics. In addition, Amber was responsible for the company's development and expansion efforts regarding clinical development programs and enterprise business operations.
Ms. Mayson received her B.A. in Psychology from Hampton University in 2018 and M.S. in Biotechnology conc. Enterprise and Entrepreneurship from Johns Hopkins University.